Press Release

Cerenome Secures National In-Network Agreement with Aetna for CNSide®

Cerenome now contracted with approximately 85% of private payers in the US, representing approximately 190 million covered lives First national CNSide payer agreement to include both tumor cell enumeration and molecular profiling HOUSTON, Nov. 04, 2026 (GLOBE NEWSWIRE) — CNSide Diagnostics, LLC, a…